CT News and Research

RSS

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

The presence of plaque on an abdominal CT scan is a strong predictor of coronary artery disease and mortality, according to a Henry Ford Hospital study.

15 Mar 2010

Supplementing vitamin D in people with low levels may have different effects based on patient race

Vitamin D is quickly becoming the "go-to" remedy for treating a wide range of illnesses, from osteoporosis to atherosclerosis. However, new evidence from a Wake Forest University School of Medicine study suggests that supplementing vitamin D in those with low levels may have different effects based on patient race and, in black individuals, the supplement could actually do harm.

15 Mar 2010

Nanoparticles provide a targeted version of photothermal therapy for cancer

In a lecture he delivered in 1906, the German physician Paul Ehrlich coined the term Zuberkugel, or "magic bullet," as shorthand for a highly targeted medical treatment.

15 Mar 2010

Sebelius attacks health insurers, they fight back

Health and Human Services Secretary Kathleen Sebelius "pleaded with insurance companies on Wednesday to scrap their campaign against President Obama's health care bill and to work with the White House to pass it," The New York Times reports.

12 Mar 2010

Study questions frequency of heart angiograms

A recent study raises questions about the frequency of doctors' use of elective heart angiograms, which showed no disease in almost 40 percent of patients. BusinessWeek reports: "Doctors may be sending patients too quickly for elective angiograms to detect heart disease, exposing them to radiation and driving up U.S. health-care costs, a study suggests.

12 Mar 2010

CoActiv Medical demonstrates EXAM-VAULT managed archiving services for orthopedic images at AAOS conference

CoActiv Medical showcases its universally accessible, affordable managed archiving services for orthopedic images and related medical data at the American Academy of Orthopaedic Surgeons conference.

11 Mar 2010

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

West Coast Neurodiagnostics & MRI, a leading network of top-notch diagnostic centers with board-certified physicians, today announced it has become Coast2Coast Diagnostics (C2C). The name change represents a nationwide expansion of the company’s renowned network and underscores its commitment to being the affordable, efficient choice for specialty medical care delivery.

11 Mar 2010

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

OVA1™, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc., the world's leading cancer diagnostics provider.

From Quest Diagnostics 10 Mar 2010

Long term care facilities receive increased scrutiny

The New York Times: "The Senate Finance Committee has opened an investigation into patient deaths and allegations of substandard treatment at long-term care hospitals, small specialty medical centers that treat chronically ill patients. The investigation focuses on the Select Medical Corporation, a for-profit corporation that runs 89 long-term care hospitals, more than any other company."

9 Mar 2010

Oldelft Benelux acquires distributorship for EOS imaging system

biospace med (www.biospacemed.com), an emerging medical technology company based in Paris, and Oldelft Benelux, a renowned specialist in medical diagnostic imaging, announced today the signature of an exclusive distribution agreement of EOS, the world’s first ultra-low-dose 2D|3D imager. The agreement will cover the distribution of EOS for the Benelux area (Belgium, The Netherlands & Luxembourg).

9 Mar 2010

Viatronix V3D-Colon software used for the President's colon cancer screening exam

Viatronix Incorporated, a Stony Brook, New York, based company announced that its V3D-Colon software is used at the National Naval Medical Center where the President's annual physical was done. "Our software is being utilized at several DOD facilities since the landmark Virtual Colonoscopy clinical trial published in the New England Journal of Medicine back in December 2003," said Zaffar Hayat, President of Viatronix Incorporated.

9 Mar 2010

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

Rcadia Medical Imaging today announced that it has received a CE Mark for the COR Analyzer® System, its proprietary software that helps identify patients with significant CAD (Coronary Artery Disease) by a fully automatic analysis of coronary CT angiography (cCTA) studies. The CE Mark allows the company to market the system in the European Union and other countries that accept the CE Mark registration. The COR Analyzer is marketed in the U.S. under 510(k) clearance and Rcadia was named 2009 Best New Radiology Vendor by AuntMinnie.com.

8 Mar 2010

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

biospace med announced today that it has received 510(k) clearance from the FDA to market the Company’s sterEOS 2D/3D workstation for pediatric use in spine applications. The Company’s EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine.

8 Mar 2010

iCAD granted patent covering SecondLook Digital CAD solution incorporating lesion metrics

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,660,448. This patent covers future iterations of iCAD’s SecondLook® Digital Computer-Aided Detection (CAD) solution with potential application to the company’s other image analysis solutions.

8 Mar 2010

Evaluating asymptomatic diabetics for CHD: Speckle Tracking by Echo ultrasound substudy sponsored

Cardiovascular death is the most common cause of mortality among Type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first “symptom” as a heart attack or sudden death. Understanding that diabetics are at high risk for Coronary Heart Disease (CHD) and that many with the disease are asymptomatic, Toshiba America Medical Systems, Inc., has sponsored Speckle Tracking by Echo, a faCTor64 substudy using Toshiba’s Wall Motion Tracking ultrasound technology.

8 Mar 2010

Endoscopic and surgical treatment of GV bleeding: MDCTPV could provide valuable references

Gastric varices (GV) are an important complication of portal hypertension. As an almost atraumatic method, computed tomography (CT) angiography has been used widely to show the portal vein system. However, the collateral circulation of GV in different locations has been reported only rarely.

6 Mar 2010

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

In an announcement today, Humanetics Corporation reported that its BIO 300 medical radiation countermeasure drug candidate has been issued a U.S. patent. The patent is assigned to the United States of America with Humanetics as the designated licensee.

5 Mar 2010

UC researchers find CT scan screening of non-smoking women is cost-effective

Researchers at the University of Cincinnati have found that it is cost-effective to do CT scan screening of non-smoking women, ages 25-54, who come to the emergency room for the first time with a collapsed lung in order to diagnose and treat those with lymphangioleiomyomatosis, or LAM.

5 Mar 2010

AMA enters health IT partnerships

The American Medical Association has made deals with computer retailer Dell, and Ingenix, a subsidiary of UnitedHealth Group, to "help physicians adopt and implement electronic health records", the Chicago Tribune reports.

4 Mar 2010

Using high-resolution CT-scans to screen for LAM is cost-effective in non-smoking women

Researchers at the University of Cincinnati have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women between 25 and 54 who come to the emergency room for the first time with a collapsed lung.

4 Mar 2010

CT News and Research

Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality

Supplementing vitamin D in people with low levels may have different effects based on patient race

Nanoparticles provide a targeted version of photothermal therapy for cancer

Sebelius attacks health insurers, they fight back

Study questions frequency of heart angiograms

CoActiv Medical demonstrates EXAM-VAULT managed archiving services for orthopedic images at AAOS conference

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

Long term care facilities receive increased scrutiny

Oldelft Benelux acquires distributorship for EOS imaging system

Viatronix V3D-Colon software used for the President's colon cancer screening exam

Rcadia Medical Imaging receives CE Mark for COR Analyzer System

biospace med receives FDA 510(k) clearance for sterEOS 2D/3D workstation for pediatric use in spine applications

iCAD granted patent covering SecondLook Digital CAD solution incorporating lesion metrics

Evaluating asymptomatic diabetics for CHD: Speckle Tracking by Echo ultrasound substudy sponsored

Endoscopic and surgical treatment of GV bleeding: MDCTPV could provide valuable references

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

UC researchers find CT scan screening of non-smoking women is cost-effective

AMA enters health IT partnerships

Using high-resolution CT-scans to screen for LAM is cost-effective in non-smoking women

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News